Featured Research

from universities, journals, and other organizations

Determine patient preferences by means of conjoint analysis

Date:
July 29, 2014
Source:
Institute for Quality and Efficiency in Health Care
Summary:
Conjoint Analysis has been tested by scientists, and is in principle suitable to find out how important different treatment goals are for patients, they conclude. Following the Analytic Hierarchy Process (AHP), CA is the second method tested by the Institute together with external experts.

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues still need to be clarified. This is the result of a pilot project by the German Institute for Quality and Efficiency in Health Care (IQWiG). Following the Analytic Hierarchy Process (AHP), CA is the second method tested by the Institute together with external experts.

Related Articles


Summarize outcome-specific results to an overall value

In its health economic evaluations IQWiG works with a particular method, the efficiency frontier concept. Efficiency frontiers can be drawn either for an aggregated outcome or for a single outcome criterion such as mortality (death rate), morbidity (symptoms and complaints) or quality of life. However, often data are only available for single outcome criteria. To summarize efficiency frontiers for different patient-relevant outcomes to an overall evaluation, that is, to aggregate them, the individual results must be weighted. Patient preferences, for example, can be used for this purpose.

Involvement of patients has so far been insufficient

In two pilot projects IQWiG has therefore tested the two most widely distributed methods used internationally to determine patient preferences. IQWiG already presented the working paper on AHP in June 2013; the working paper on CA is now also available.

Patients are in a way the "end-consumers" of medical interventions. In many countries they are therefore involved in the assessments of benefits and costs. However, so far this has not happened in a systematic, transparent and reproducible way. In addition, purely qualitative approaches are generally used, but not quantitative ones such as CA or AHP.

Both patients and physicians questioned

Using a choice-based variation of CA (discrete choice experiment) the researchers questioned both patients with chronic hepatitis C (HCV) and healthcare professionals involved in their care -- first in separate focus groups and then by means of questionnaires. A total of 326 patients and 21 physicians participated.

The questions referred to different dimensions of benefits and harms: effectiveness (e.g. absence of the virus, also called "sustained virological response"), avoidance of side effects (e.g. gastro-intestinal complaints), as well as effort involved (e.g. frequency of injections), and duration of treatment.

Respondents were to choose between "scenarios"

The participants were to choose 18 times between two fictitious treatment alternatives that were composed of various treatment characteristics (attributes) and that differed according to the levels of the characteristics.

The levels of a total of seven attributes were varied multiple times and repeatedly recombined: In such a scenario, Treatment A lasted 48 weeks and Treatment B lasted 24 weeks; the probability of gastro-intestinal complaints was 35% (A) and 25% (B). In the next scenario, with 12 weeks, Treatment A only lasted half as long as Treatment B (24 weeks); the risk of gastro-intestinal side effects was clearly lower for A than for B (25% versus 45%).

Patient preferences versus opinions of healthcare professionals

If the results of all of these choices are analysed using logistic regression models, it is possible to derive the relative importance (weighting) of the individual treatment attributes. For example, it can be calculated how much higher the chance of cure (absence of the virus) must be so that patients accept a certain higher risk of more frequent or more severe side effects.

A comparison of the analysis of patients and physicians shows that the sequence of treatment goals is largely congruent. However, differences exist in the strength of weighting: In both groups "sustained absence of the virus" is ranked in first place; however, if they are to choose a treatment, this attribute is even more crucial for physicians than for patients.

CA is manageable for patients

After this pilot project, IQWiG assesses the CA -- as previously the AHP -- to be a basically suitable and manageable method. "Patients can handle the procedure and it delivers useful results. One could thus employ the CA for weighting outcomes," says Andreas Gerber-Grote, Head of IQWiG's Health Economics Department.

Both procedures have strengths and weaknesses

Whereas the CA works with multidimensional scenarios, the AHP in each case involves pairwise comparisons (e.g. duration of treatment versus side effects). "For the CA one could thus say that the procedure is closer to decision-making situations as they occur in the real world. The attributes are always assessed here in a batch," explains Gerber-Grote. "However, the complexity of the decision increases with the number of attributes. If one only considers two attributes at the same time -- as in the AHP -- this is more transparent for respondents."

Clarify methodological issues before widespread use

According to the Deputy Director of the Institute, Stefan Lange, one should bear in mind that "both pilot projects were successful, but before we can widely use CA or AHP in assessments, a whole range of challenges still exist, primarily of a methodological nature."

He added: "It needs to be clarified beforehand who is to be questioned: patients, physicians or -- as in the United Kingdom -- a sample of the general population? In any case an agreement is required on how representative the selection of respondents has to be. And one needs to determine which degree of precision is required, i.e., how robust the results have to be. This is because the higher the demands, the more people have to be questioned, and the greater the effort involved. Unlike in clinical studies, no standards exist so far as to how the sample size should be planned."


Story Source:

The above story is based on materials provided by Institute for Quality and Efficiency in Health Care. Note: Materials may be edited for content and length.


Cite This Page:

Institute for Quality and Efficiency in Health Care. "Determine patient preferences by means of conjoint analysis." ScienceDaily. ScienceDaily, 29 July 2014. <www.sciencedaily.com/releases/2014/07/140729093110.htm>.
Institute for Quality and Efficiency in Health Care. (2014, July 29). Determine patient preferences by means of conjoint analysis. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2014/07/140729093110.htm
Institute for Quality and Efficiency in Health Care. "Determine patient preferences by means of conjoint analysis." ScienceDaily. www.sciencedaily.com/releases/2014/07/140729093110.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) — Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) — A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins